Liver Hepatocellular Carcinoma: Correlation between copy number variations of arm-level result and selected clinical features
(primary solid tumor cohort)
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Overview
Introduction

This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.

Summary

Testing the association between copy number variation 64 arm-level results and 8 clinical features across 68 patients, one significant finding detected with Q value < 0.25.

  • 18p loss cnv correlated to 'AGE'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 64 arm-level results and 8 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, one significant finding detected.

Clinical
Features
Time
to
Death
AGE GENDER DISTANT
METASTASIS
LYMPH
NODE
METASTASIS
COMPLETENESS
OF
RESECTION
TUMOR
STAGECODE
NEOPLASM
DISEASESTAGE
nCNV (%) nWild-Type logrank test t-test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test t-test Chi-square test
18p loss 7 (10%) 61 0.00678
(1.00)
0.000506
(0.221)
0.691
(1.00)
0.709
(1.00)
0.271
(1.00)
1
(1.00)
0.703
(1.00)
1p gain 8 (12%) 60 0.507
(1.00)
0.145
(1.00)
1
(1.00)
0.208
(1.00)
0.122
(1.00)
0.0782
(1.00)
0.0681
(1.00)
1q gain 36 (53%) 32 0.995
(1.00)
0.863
(1.00)
0.208
(1.00)
0.524
(1.00)
0.507
(1.00)
0.916
(1.00)
0.153
(1.00)
2p gain 8 (12%) 60 0.349
(1.00)
0.105
(1.00)
0.12
(1.00)
0.491
(1.00)
0.323
(1.00)
0.207
(1.00)
0.893
(1.00)
2q gain 7 (10%) 61 0.483
(1.00)
0.209
(1.00)
0.0875
(1.00)
0.709
(1.00)
0.485
(1.00)
0.474
(1.00)
0.893
(1.00)
3p gain 3 (4%) 65 0.87
(1.00)
0.042
(1.00)
1
(1.00)
1
(1.00)
0.0232
(1.00)
0.618
(1.00)
0.000998
(0.434)
3q gain 3 (4%) 65 0.87
(1.00)
0.042
(1.00)
1
(1.00)
1
(1.00)
0.0232
(1.00)
0.618
(1.00)
0.000998
(0.434)
4p gain 5 (7%) 63 0.786
(1.00)
0.215
(1.00)
0.337
(1.00)
1
(1.00)
1
(1.00)
0.805
(1.00)
0.662
(1.00)
5p gain 20 (29%) 48 0.387
(1.00)
0.107
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
0.812
(1.00)
0.954
(1.00)
5q gain 14 (21%) 54 0.442
(1.00)
0.133
(1.00)
1
(1.00)
1
(1.00)
0.798
(1.00)
0.688
(1.00)
0.887
(1.00)
6p gain 13 (19%) 55 0.127
(1.00)
0.696
(1.00)
0.355
(1.00)
0.273
(1.00)
0.606
(1.00)
0.0847
(1.00)
0.474
(1.00)
6q gain 9 (13%) 59 0.0769
(1.00)
0.241
(1.00)
0.476
(1.00)
0.176
(1.00)
0.75
(1.00)
0.0445
(1.00)
0.261
(1.00)
7p gain 18 (26%) 50 0.772
(1.00)
0.622
(1.00)
0.395
(1.00)
1
(1.00)
0.832
(1.00)
0.792
(1.00)
0.973
(1.00)
7q gain 19 (28%) 49 0.415
(1.00)
0.554
(1.00)
0.574
(1.00)
0.56
(1.00)
0.683
(1.00)
0.792
(1.00)
0.868
(1.00)
8p gain 11 (16%) 57 0.268
(1.00)
0.637
(1.00)
0.305
(1.00)
0.188
(1.00)
1
(1.00)
0.102
(1.00)
0.212
(1.00)
8q gain 33 (49%) 35 0.614
(1.00)
0.745
(1.00)
0.454
(1.00)
0.518
(1.00)
0.355
(1.00)
0.841
(1.00)
0.669
(1.00)
9p gain 3 (4%) 65 0.856
(1.00)
0.283
(1.00)
1
(1.00)
1
(1.00)
0.618
(1.00)
0.925
(1.00)
9q gain 3 (4%) 65 0.856
(1.00)
0.283
(1.00)
1
(1.00)
1
(1.00)
0.618
(1.00)
0.925
(1.00)
10p gain 5 (7%) 63 0.0729
(1.00)
0.365
(1.00)
0.337
(1.00)
0.108
(1.00)
0.0679
(1.00)
0.434
(1.00)
0.925
(1.00)
12q gain 3 (4%) 65 0.927
(1.00)
0.283
(1.00)
0.565
(1.00)
1
(1.00)
0.618
(1.00)
0.97
(1.00)
15q gain 5 (7%) 63 0.511
(1.00)
0.309
(1.00)
0.337
(1.00)
0.371
(1.00)
0.221
(1.00)
0.805
(1.00)
0.482
(1.00)
16p gain 3 (4%) 65 0.00316
(1.00)
0.142
(1.00)
1
(1.00)
0.282
(1.00)
0.251
(1.00)
1
(1.00)
17p gain 3 (4%) 65 0.288
(1.00)
0.691
(1.00)
0.283
(1.00)
0.0748
(1.00)
0.0686
(1.00)
0.618
(1.00)
17q gain 17 (25%) 51 0.112
(1.00)
0.702
(1.00)
0.571
(1.00)
0.663
(1.00)
0.404
(1.00)
0.921
(1.00)
0.874
(1.00)
18q gain 3 (4%) 65 0.522
(1.00)
0.567
(1.00)
1
(1.00)
0.565
(1.00)
0.568
(1.00)
0.618
(1.00)
0.376
(1.00)
19p gain 5 (7%) 63 0.431
(1.00)
0.597
(1.00)
0.0489
(1.00)
1
(1.00)
0.662
(1.00)
1
(1.00)
0.703
(1.00)
19q gain 7 (10%) 61 0.572
(1.00)
0.804
(1.00)
0.0875
(1.00)
0.709
(1.00)
0.485
(1.00)
0.571
(1.00)
0.665
(1.00)
20p gain 12 (18%) 56 0.0785
(1.00)
0.0748
(1.00)
0.321
(1.00)
0.596
(1.00)
0.312
(1.00)
0.0793
(1.00)
0.674
(1.00)
20q gain 13 (19%) 55 0.139
(1.00)
0.0498
(1.00)
0.52
(1.00)
0.793
(1.00)
0.347
(1.00)
0.0243
(1.00)
0.531
(1.00)
21q gain 4 (6%) 64 0.415
(1.00)
0.567
(1.00)
0.122
(1.00)
0.617
(1.00)
0.604
(1.00)
1
(1.00)
0.662
(1.00)
22q gain 7 (10%) 61 0.134
(1.00)
0.026
(1.00)
0.233
(1.00)
0.709
(1.00)
0.0579
(1.00)
0.841
(1.00)
0.0113
(1.00)
Xq gain 4 (6%) 64 0.123
(1.00)
0.169
(1.00)
1
(1.00)
0.153
(1.00)
0.604
(1.00)
0.726
(1.00)
0.623
(1.00)
1p loss 13 (19%) 55 0.888
(1.00)
0.953
(1.00)
0.52
(1.00)
1
(1.00)
0.265
(1.00)
1
(1.00)
0.117
(1.00)
1q loss 4 (6%) 64 0.851
(1.00)
0.0444
(1.00)
0.61
(1.00)
0.617
(1.00)
0.0192
(1.00)
1
(1.00)
0.000998
(0.434)
2p loss 3 (4%) 65 0.283
(1.00)
1
(1.00)
1
(1.00)
0.618
(1.00)
0.91
(1.00)
2q loss 4 (6%) 64 0.00697
(1.00)
0.61
(1.00)
1
(1.00)
1
(1.00)
0.207
(1.00)
0.992
(1.00)
3p loss 5 (7%) 63 0.866
(1.00)
0.729
(1.00)
0.337
(1.00)
1
(1.00)
1
(1.00)
0.805
(1.00)
0.736
(1.00)
3q loss 3 (4%) 65 0.674
(1.00)
0.345
(1.00)
0.283
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
4p loss 9 (13%) 59 0.257
(1.00)
0.917
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
0.919
(1.00)
4q loss 16 (24%) 52 0.504
(1.00)
0.984
(1.00)
0.773
(1.00)
1
(1.00)
1
(1.00)
0.917
(1.00)
0.69
(1.00)
5q loss 4 (6%) 64 0.00285
(1.00)
0.982
(1.00)
1
(1.00)
0.617
(1.00)
0.604
(1.00)
0.318
(1.00)
0.925
(1.00)
6q loss 11 (16%) 57 0.428
(1.00)
0.84
(1.00)
0.5
(1.00)
1
(1.00)
1
(1.00)
0.372
(1.00)
0.986
(1.00)
7p loss 5 (7%) 63 0.523
(1.00)
0.695
(1.00)
0.0489
(1.00)
1
(1.00)
0.662
(1.00)
0.805
(1.00)
0.0323
(1.00)
7q loss 7 (10%) 61 0.656
(1.00)
0.465
(1.00)
0.233
(1.00)
0.472
(1.00)
1
(1.00)
0.335
(1.00)
0.227
(1.00)
8p loss 30 (44%) 38 0.252
(1.00)
0.108
(1.00)
0.307
(1.00)
0.78
(1.00)
0.226
(1.00)
1
(1.00)
0.389
(1.00)
8q loss 5 (7%) 63 0.394
(1.00)
0.814
(1.00)
0.337
(1.00)
1
(1.00)
0.662
(1.00)
0.434
(1.00)
0.149
(1.00)
9p loss 16 (24%) 52 0.937
(1.00)
0.504
(1.00)
0.773
(1.00)
1
(1.00)
0.816
(1.00)
0.516
(1.00)
0.631
(1.00)
9q loss 14 (21%) 54 0.646
(1.00)
0.545
(1.00)
0.755
(1.00)
1
(1.00)
1
(1.00)
0.567
(1.00)
0.672
(1.00)
10p loss 3 (4%) 65 0.574
(1.00)
0.0303
(1.00)
0.547
(1.00)
0.282
(1.00)
1
(1.00)
0.201
(1.00)
10q loss 12 (18%) 56 0.237
(1.00)
0.724
(1.00)
0.741
(1.00)
0.596
(1.00)
0.58
(1.00)
0.316
(1.00)
0.681
(1.00)
11p loss 5 (7%) 63 0.643
(1.00)
0.348
(1.00)
0.337
(1.00)
1
(1.00)
0.221
(1.00)
0.805
(1.00)
0.376
(1.00)
11q loss 8 (12%) 60 0.618
(1.00)
0.409
(1.00)
1
(1.00)
1
(1.00)
0.727
(1.00)
0.0384
(1.00)
0.423
(1.00)
12p loss 4 (6%) 64 0.323
(1.00)
0.224
(1.00)
0.61
(1.00)
0.336
(1.00)
0.066
(1.00)
0.726
(1.00)
0.0099
(1.00)
13q loss 23 (34%) 45 0.397
(1.00)
0.255
(1.00)
1
(1.00)
0.26
(1.00)
0.855
(1.00)
0.214
(1.00)
0.148
(1.00)
14q loss 22 (32%) 46 0.563
(1.00)
0.56
(1.00)
0.591
(1.00)
0.72
(1.00)
0.189
(1.00)
0.602
(1.00)
0.219
(1.00)
15q loss 7 (10%) 61 0.803
(1.00)
0.354
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
0.841
(1.00)
0.863
(1.00)
16p loss 14 (21%) 54 0.84
(1.00)
0.568
(1.00)
1
(1.00)
0.301
(1.00)
0.235
(1.00)
0.00851
(1.00)
0.0306
(1.00)
16q loss 22 (32%) 46 0.891
(1.00)
0.303
(1.00)
0.591
(1.00)
0.119
(1.00)
0.501
(1.00)
0.17
(1.00)
0.374
(1.00)
17p loss 28 (41%) 40 0.247
(1.00)
0.382
(1.00)
1
(1.00)
0.0468
(1.00)
0.0611
(1.00)
0.399
(1.00)
0.67
(1.00)
17q loss 3 (4%) 65 0.818
(1.00)
0.0172
(1.00)
0.283
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
18q loss 9 (13%) 59 0.0875
(1.00)
0.000836
(0.364)
0.71
(1.00)
1
(1.00)
0.235
(1.00)
1
(1.00)
0.831
(1.00)
19p loss 5 (7%) 63 0.33
(1.00)
0.235
(1.00)
0.153
(1.00)
1
(1.00)
1
(1.00)
0.295
(1.00)
0.847
(1.00)
21q loss 9 (13%) 59 0.0284
(1.00)
0.82
(1.00)
0.0217
(1.00)
1
(1.00)
1
(1.00)
0.251
(1.00)
0.664
(1.00)
22q loss 9 (13%) 59 0.484
(1.00)
0.738
(1.00)
0.0579
(1.00)
1
(1.00)
0.512
(1.00)
0.0661
(1.00)
0.59
(1.00)
'18p loss mutation analysis' versus 'AGE'

P value = 0.000506 (t-test), Q value = 0.22

Table S1.  Gene #60: '18p loss mutation analysis' versus Clinical Feature #2: 'AGE'

nPatients Mean (Std.Dev)
ALL 66 61.5 (14.2)
18P LOSS MUTATED 7 73.6 (6.4)
18P LOSS WILD-TYPE 59 60.0 (14.2)

Figure S1.  Get High-res Image Gene #60: '18p loss mutation analysis' versus Clinical Feature #2: 'AGE'

Methods & Data
Input
  • Mutation data file = broad_values_by_arm.mutsig.cluster.txt

  • Clinical data file = LIHC-TP.clin.merged.picked.txt

  • Number of patients = 68

  • Number of significantly arm-level cnvs = 64

  • Number of selected clinical features = 8

  • Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Student's t-test analysis

For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Chi-square test

For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[3] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[4] Greenwood and Nikulin, A guide to chi-squared testing, Wiley, New York. ISBN 047155779X (1996)
[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)